7 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 7 of 7 clinical reviews.
A clinician-level guide to managing adverse events from NAD precursors (NMN, NR, niacin), including dosing thresholds, monitoring parameters, drug interactions, and step-by-step mitigation protocols backed by primary-source evidence.
A practical, MD/PharmD-level guide to billing codes, prior-authorization strategies, and prescribing essentials for NAD precursor therapies including NMN, NR, and IV NAD+.
Clinical monograph covering the NAD precursor drug class, including nicotinamide riboside (NR), nicotinamide mononucleotide (NMN), niacin, and nicotinamide. Mechanisms, pharmacokinetics, trial data, dosing, safety, and prescribing considerations.
A prescriber-level monitoring bundle for NAD precursor therapy (NMN, NR, niacin, niacinamide) covering baseline labs, follow-up intervals, safety signals, and dose-adjustment triggers.
A clinician-level review of NAD precursor pharmacology, dosing, safety, and special-population considerations including pregnancy, renal impairment, oncology patients, and older adults. Evidence-based with primary citations.
A physician- and pharmacist-level review of NAD precursor drugs (NMN, NR, niacin), including evidence-based titration schedules, tapering protocols, dosing algorithms, and safety monitoring parameters.
A clinician-level guide to NMN, NR, niacin, and nicotinamide, comparing pharmacokinetics, tissue delivery, clinical evidence, and practical prescribing decisions for NAD precursor therapy.